The company can release news at any time. It's if they want to present data finding at a conference, that would be embargo, that will likely need to wait until the next conference.
There are so many catalyst. Some we know, and others we do not. :)
I trust they know what they're doing and I'm going to be the patient shareholder that I've always been and give them room to do it. I can't help but debate the negative timeline points, as results can't be rushed. This is a biotech stock, so times of lull are shorted. Imagine it was determined months ago they weren't going to be presenting at ASCO. Shorts would have swarmed. In my mind, the company could have easily, and I mean easily, just bought booth space to ensure our share price was not manipulated over it. We only found out yesterday they wouldn't be presenting. To me that is very effective managment strategy, keep the world thinking they could reveal something any day, week or month. The more I see of this, the more I like. They potentially saved my share price from falling down by not revealing that card that the data wouldn't be there. But, did ASCO ever make sense? In my mind, not completely. I keep going back to that vaccine schedule, and this being immunotherapy, which needs even that last vaccine data to age (it's not like they can inject in May and Ph I ends that date (it needs months). The DATA not being ready, IS NOT the same thing as the data didn't get accepted. Only now, we're near the end of April, and so much closer to the next catalyst. I haven't even looked at the ticker, as it just doesn't matter, as we are always getting close to the next thing, and in the interim, the data is aging. Long hold shareholder think that way.
BUT, will I be here to debate, until I'm exhausted sometimes, all the negative points? Absolutely. I won't get angry doing it, as to me, it's not personal. I just don't read into it. Period.
AI
Market Data 
Markets 
